Vanguard Personalized Indexing Management’s CG Oncology CGON Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio CGON Stock Details CGON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$351K	Buy	+5,184	New	+$294K	﹤0.01%	1520

Other funds holding CGON

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Vanguard Personalized Indexing Management's CGON Position: Q1 2026 in Review

Vanguard Personalized Indexing Management opened a new position in CG Oncology (CGON) in Q1 2026: 5,184 shares worth $351K. The stake represents ﹤0.01% of the portfolio and ranks #1520 among its holdings.

233 funds tracked by Wall St. Rank hold CGON as of Q1 2026.

Vanguard Personalized Indexing Management held 5,184 shares of CG Oncology worth $351K as of Q1 2026.
CG Oncology was a new Vanguard Personalized Indexing Management position in Q1 2026.
CG Oncology made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q1 2026, its #1520 holding.
233 funds tracked by Wall St. Rank held CG Oncology as of Q1 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q1 2026, filed 14 May 2026.